Showing results (151-160 of 755) with videos related to

Sort By:
Pageof 76
The Journal of Neuropsychiatry and Clinical Neurosciences|August 10, 1999
Neurological function during long-term therapy with recombinant interferon alphaN Mayr, J Zeitlhofer, L Deecke, et al.
British Journal of Haematology|July 1, 1993
Immunophenotypic characterization of myelomonocytic cells in patients with myelodysplastic syndromeT Felzmann, H Gisslinger, O Krieger, et al.
British Journal of Haematology|December 19, 1998
Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to ValW R Sperr, S Walchshofer, H P Horny, et al.
Blood|July 15, 1997
Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III studyK Geissler, E Koller, E Hubmann, et al.
Clinical & Experimental Metastasis|February 5, 2009
Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategiesGudrun E Koehl, Andreas Gaumann, Edward K Geissler
Current Opinion in Organ Transplantation|December 22, 2011
Human regulatory macrophages as a cell-based medicinal productJames A Hutchinson, Paloma Riquelme, Edward K Geissler
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Soluble donor MHC class I antigen inhibits immunologic priming in vitro and in vivoE K Geissler, M N Scherer, C Graeb
Prostaglandins|October 1, 1990
Impaired conversion of exogenous arachidonic acid by platelets to thromboxane B2 and correction of that deficiency by interferon-alphaH Sinzinger, W Linkesch, H Ludwig, et al.
Transplantation|October 6, 1997
Secreted donor-MHC class I antigen prolongs liver allograft survival and inhibits recipient anti-donor cytotoxic T lymphocyte responsesE K Geissler, W J Korzun, C Graeb
Wiener Klinische Wochenschrift|November 4, 1988
[Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid]H Sinzinger, H Gisslinger, W Linkesch, et al.
Pageof 76